Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2011 2
2012 1
2013 1
2014 2
2015 2
2018 1
2019 2
2020 3
2021 3
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Baboon syndrome and toxic erythema of chemotherapy: Fold (intertriginous) dermatoses.
Wolf R, Tüzün Y. Wolf R, et al. Clin Dermatol. 2015 Jul-Aug;33(4):462-5. doi: 10.1016/j.clindermatol.2015.04.008. Epub 2015 Apr 7. Clin Dermatol. 2015. PMID: 26051062 Review.
Another intertriginous drug eruption is the one induced by chemotherapy. Toxic erythema of chemotherapy (TEC) is a useful clinical term that recently has been introduced to describe this group of chemotherapy-induced eruptions. This group of overlappin …
Another intertriginous drug eruption is the one induced by chemotherapy. Toxic erythema of chemotherapy (TEC) is …
Cutaneous manifestations in pediatric oncology patients.
Özkur E, Sert C, Kıvanç Altunay İ, Yıldırırmak ZY, Genç DB, Vural S, Erdem Y. Özkur E, et al. Pediatr Dermatol. 2021 Jan;38(1):58-65. doi: 10.1111/pde.14375. Epub 2020 Nov 12. Pediatr Dermatol. 2021. PMID: 33179835
Five patients (6.2%) had drug-induced cutaneous hyperpigmentation, and five (6.2%) had toxic erythema of chemotherapy. The highest percentage of xerosis (45.4%) was detected in patients using antitumor antibiotics, whereas inflammatory dermatoses were …
Five patients (6.2%) had drug-induced cutaneous hyperpigmentation, and five (6.2%) had toxic erythema of chemotherap …
Toxic erythema of chemotherapy: a useful clinical term.
Bolognia JL, Cooper DL, Glusac EJ. Bolognia JL, et al. J Am Acad Dermatol. 2008 Sep;59(3):524-9. doi: 10.1016/j.jaad.2008.05.018. J Am Acad Dermatol. 2008. PMID: 18694683 No abstract available.
Toxic erythema of chemotherapy induced by liposomal doxorubicin, a clinical case.
Esperanca-Martins M, Lobo-Martins S, Sanches M, Brazao C, Pena B, Correia C, Aguado-Lobo M, Espinosa-Lara P, Costa L, Soares-de-Almeida L, Fernandes I. Esperanca-Martins M, et al. Dermatol Online J. 2022 Jan 15;28(1). doi: 10.5070/D328157060. Dermatol Online J. 2022. PMID: 35499414
Oral corticosteroids were started, treatment with liposomal doxorubicin was stopped, and cutaneous biopsies performed that revealed features compatible with toxic erythema of chemotherapy induced by liposomal doxorubicin. ...
Oral corticosteroids were started, treatment with liposomal doxorubicin was stopped, and cutaneous biopsies performed that revealed features …
A review of important skin disorders occurring in the posttransplantation patient.
Sundram U. Sundram U. Adv Anat Pathol. 2014 Sep;21(5):321-9. doi: 10.1097/PAP.0000000000000033. Adv Anat Pathol. 2014. PMID: 25105934 Review.
Common among these are acute and chronic graft-versus-host disease, erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis, eruption of lymphocyte recovery, staphylococcal scalded skin syndrome, morbiliform drug eruptions, infections, and toxic erythem …
Common among these are acute and chronic graft-versus-host disease, erythema multiforme, Stevens-Johnson syndrome/toxic epidermal necrolysis …
Toxic erythema of chemotherapy.
Repass TS, Wetter DA, Camilleri MJ. Repass TS, et al. Am J Hematol. 2012 Sep;87(9):923. doi: 10.1002/ajh.22200. Epub 2011 Nov 10. Am J Hematol. 2012. PMID: 22072527 Free article. No abstract available.
Toxic erythema of chemotherapy secondary to gemcitabine and paclitaxel.
Jennings E, Huang S, Lee JB, Cha J, Hsu S. Jennings E, et al. Dermatol Online J. 2020 Sep 15;26(9):13030/qt86m5f6hh. Dermatol Online J. 2020. PMID: 33054938 Free article.
Toxic erythema of chemotherapy (TEC) is an infrequently reported cutaneous condition, with diagnosis predominately based on clinical presentation, histologic findings, and known reported associations. ...
Toxic erythema of chemotherapy (TEC) is an infrequently reported cutaneous condition, with diagnosis predominate …
Clinical and histopathological spectrum of toxic erythema of chemotherapy in patients who have undergone allogeneic hematopoietic cell transplantation.
Hunjan MK, Nowsheen S, Ramos-Rodriguez AJ, Hashmi SK, Bridges AG, Lehman JS, El-Azhary R. Hunjan MK, et al. Hematol Oncol Stem Cell Ther. 2019 Mar;12(1):19-25. doi: 10.1016/j.hemonc.2018.09.001. Epub 2018 Sep 20. Hematol Oncol Stem Cell Ther. 2019. PMID: 30248313 Free article.
OBJECTIVE/BACKGROUND: Toxic erythema of chemotherapy (TEC) is a well-recognized adverse cutaneous reaction to chemotherapy. ...
OBJECTIVE/BACKGROUND: Toxic erythema of chemotherapy (TEC) is a well-recognized adverse cutaneous reaction to ch …
Toxic erythema of chemotherapy affecting the ears of an infant: A case report.
Tamazian S, Oboite M, Larijani M, Oliver B, Milbar H, Jen M, Treat JR. Tamazian S, et al. Pediatr Dermatol. 2021 Mar;38(2):512-513. doi: 10.1111/pde.14522. Epub 2021 Jan 22. Pediatr Dermatol. 2021. PMID: 33481261
A 15-month-old boy presented with new onset symmetric erythema of the conchal bowls bilaterally in the setting of treatment with cytarabine. Findings were consistent with a diagnosis of toxic erythema of chemotherapy, an adverse effect of chemotherapy. …
A 15-month-old boy presented with new onset symmetric erythema of the conchal bowls bilaterally in the setting of treatment with cytarabine. …
18 results